Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003;24:1121–31.PubMedCrossrefGoogle Scholar
Monnery BD, Wright M, Cavill R, Hoogenboom R, Shaunak S, Steinke JH, et al. Cytotoxicity of polycations: relationship of molecular weight and the hydrolytic theory of the mechanism of toxicity. Int J Pharm 2017;521:249–58.CrossrefWeb of SciencePubMedGoogle Scholar
Kalaska B, Kaminski K, Sokolowska E, Czaplicki D, Kujdowicz M, Stalinska K, et al. Nonclinical evaluation of novel cationically modified polysaccharide antidotes for unfractionated heparin. PLoS One 2015;10:e0119486.Web of SciencePubMedGoogle Scholar
Marini JJ, Wheeler AP. Critical care medicine. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2010.Google Scholar
Lewis SL. Medical surgical nursing. St. Louis, MI, USA: Elsevier - Mosby, 2017.Google Scholar
Kalaska B, Sokolowska E, Kaminski K, Szczubialka K, Kramkowski K, Mogielnicki A, et al. Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis. Eur J Pharmacol 2012;686:81–9.Web of ScienceCrossrefPubMedGoogle Scholar
Sznarkowska A, Olszewski R, Zawacka-Pankau J. Pharmacological activation of tumor suppressor, wild-type p53 as a promising strategy to fight cancer. Postępy Hig Med Dosw 2010;64:396–407.Google Scholar
Tassi E, Al-Attar A, Aigner A, Swift MR, McDonnell K, Karavanov A, et al. Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein. J Biol Chem 2001;276:40247–53.CrossrefPubMedGoogle Scholar
About the article
Published Online: 2018-12-07
Conflict of interests: The authors declare no conflict of interest.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: The Polish National Science Centre (grant no. UMO-2013/09/D/ST5/03864).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.